ALXP
ALPRE
Market cap4mUSD
Oct 27, Last price
0.92EUR
1D
-8.91%
1Q
-23.33%
IPO
-90.11%
Name
Predilife SA
Chart & performance
P/E
—
P/S
3.25
EPS
—
Vol. 1Y
67.01%
Shs. 5Y
—
Rev. 5Y
-20.63%
Div Yld LY
—
Div Yld TTM
—
Revenues
1m
Net income
-4m
CFO
-3m
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Founded in 2004 and headquartered in Villejuif, France, Predilife S.A. specializes in devising and commercializing sophisticated medical technologies and analytical models. The company's core offerings include preventative healthcare solutions and comprehensive breast screening tests. Among its notable products are MammoRisk, a diagnostic tool designed to forecast an individual's risk of developing breast cancer; DenSeeMammo, software for evaluating breast tissue density; and a specialized medical device developed for predicting prostate cancer risk.
Related entities
Subsidiaries
MAMMORISK
Headquarters & legal address
39 RUE CAMILLE DESMOULINS
IGR CAMPUS CANCER 1 BATIMENT MAURICE
VILLEJUIF 94800
FR
IGR CAMPUS CANCER 1 BATIMENT MAURICE
VILLEJUIF 94800
FR
Valuation
Title EUR in thousands, except ratios and share amounts | FY |
|---|---|
| 2025‑12 | |
| Income | |
Revenues | |
Cost of revenue | |
Unusual Expense (Income) | |
NOPBT | |
NOPBT Margin | |
Operating Taxes | |
Tax Rate | |
NOPAT | |
Net income | |
Dividends | |
Dividend yield | |
Proceeds from repurchase of equity | |
BB yield | |
| Debt | |
Debt current | |
Long-term debt | |
Deferred revenue | |
Other long-term liabilities | |
Net debt | |
| Cash flow | |
Cash from operating activities | |
CAPEX | |
Cash from investing activities | |
Cash from financing activities | |
FCF | |
| Balance | |
Cash | |
Long term investments | |
Excess cash | |
Stockholders' equity | |
Invested Capital | |
ROIC | |
ROCE | |
| EV | |
Common stock shares outstanding | |
Price | |
Market cap | |
EV | |
EBITDA | |
EV/EBITDA | |
Interest | |
Interest/NOPBT | |